Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DPCP Ointment for Alopecia Areata
NCT03651752Phase 3Terminated
- Sponsor
- University of Minnesota
- Start
- Apr 2024
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of diphencyprone in alopecia areata, sponsored by University of Minnesota. Primary endpoint: Increased Hair Growth as Assessed by SALT Score at 18 weeks. Started Apr 2024; status: terminated.
02
Drugs
diphencyprone
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT03651752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03651752.